The repeatability of operations is one of the success factors for plants wishing to improve their competitiveness and the quality of their products. Operators must be able to reproduce the same actions to ensure [...]
Non-conformities represent one of the main sources of revenue loss for industrial companies. In a rapidly changing environment where the various players are seeking to optimize their processes and improve their quality in order [...]
The industrial sector has always suffered from a high turnover rate and in recent years has faced difficulties in recruiting and attracting and retaining young talent. It is believed that the ideal solution to [...]
Seveso sites are industrial sites that present a high risk of major incidents endangering the health of workers and the surrounding environment (animals, humans, plants, etc.). These sites are subject to a risk management [...]
In recent years, one of the biggest challenges facing industrial companies is the difficulty in recruiting new talent to succeed retiring employees. This translates into a slowdown in the pace of development planned for [...]
Any professional activity involves an element of risk. The world of industry is no exception; operators operate in the midst of equipment that is sometimes heavy, bulky, powerful, and sometimes in the presence of [...]
In an industrial environment undergoing rapid digital change, the digitalization of work instructions is essential to enable companies to motivate their teams, improve safety at work and, above all, boost operational excellence. The digitization [...]
In the pharmaceutical industry, deviations are one of the main causes of lost profits. Being high-risk, non-compliances are not tolerated and therefore need to be corrected. This inflicts a loss of turnover on the [...]
In pharmaceutical plants, the cleaning and disinfection of lines is particularly important. Production lines must be in perfect condition before changing series, and faults cannot be tolerated because of the heavy consequences they can [...]
Although the digital transformation is affecting different sectors, the pharmaceutical industry has experienced a slow transition to integrate connected technologies. In fact, this delay can be explained by the delicate and highly regulated nature [...]
